Literature DB >> 7570405

Validation of an asthma quality of life diary in a clinical trial.

M E Hyland1, G R Crocker.   

Abstract

BACKGROUND: Quality of life (QOL) is commonly measured in asthma clinical trials by a questionnaire given before and after treatment. A structured asthma QOL daily diary provides more restricted information but on a daily basis. The validity and use of such a QOL diary was examined in a clinical trial in which two asthma treatments were compared.
METHODS: The effects of low dose inhaled steroid (400 micrograms beclomethasone dipropionate, BDP) combined with the long acting beta 2 agonist salmeterol (100 micrograms) (n = 220) was compared with high dose inhaled steroid (1000 micrograms BDP) (n = 206) in asthmatic outpatients in a double blind, parallel group study. Outcome measures consisted of a combined diary for peak expiratory flow (PEF) rate, symptoms, and problems, and an asthma-specific QOL questionnaire, the Living with Asthma Questionnaire.
RESULTS: The QOL diary correlated with the QOL questionnaire for both cross sectional and longitudinal assessments. Cross sectional correlations with PEF were higher for the QOL questionnaire than the QOL diary, but longitudinal correlations with PEF were higher for the diary than the questionnaire. Treatment with low dose steroid/salmeterol compared with high dose steroid produced better lung function, better QOL as measured by diary, and reduced night time wakenings, but treatment differences were not obtained with the QOL questionnaire nor for daytime symptoms. Diary assessed QOL was a better predictor of low PEF than diary assessed symptoms. Compliance with diary completion was good but there were floor or ceiling effects in the QOL diary records of about 25% of patients.
CONCLUSIONS: Structured QOL diaries are valid instruments that appear to be more responsive to longitudinal change in clinical trials than a QOL questionnaire, but QOL questionnaires provide a more sensitive cross sectional measure of disease severity. Floor and ceiling effects are found in some patients' QOL diaries which limit their usefulness. QOL diary problem events occur during the troughs of a peak flow graph, while symptoms are more widely distributed with respect to peak flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570405      PMCID: PMC474643          DOI: 10.1136/thx.50.7.724

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  A life activities questionnaire for adult asthma.

Authors:  T L Creer; J K Wigal; H Kotses; K McConnaughy; J A Winder
Journal:  J Asthma       Date:  1992       Impact factor: 2.515

2.  Measuring health status: what are the necessary measurement properties?

Authors:  G H Guyatt; B Kirshner; R Jaeschke
Journal:  J Clin Epidemiol       Date:  1992-12       Impact factor: 6.437

3.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

4.  A scale for assessing quality of life in adult asthma sufferers.

Authors:  M E Hyland; S Finnis; S H Irvine
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

5.  Problems of recall and misclassification with checklist methods of measuring stressful life events.

Authors:  K G Raphael; M Cloitre; B P Dohrenwend
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

6.  A scale for the measurement of quality of life in adults with asthma.

Authors:  G B Marks; S M Dunn; A J Woolcock
Journal:  J Clin Epidemiol       Date:  1992-05       Impact factor: 6.437

7.  A reformulation of quality of life for medical science.

Authors:  M E Hyland
Journal:  Qual Life Res       Date:  1992-08       Impact factor: 4.147

8.  A methodological framework for assessing health indices.

Authors:  B Kirshner; G Guyatt
Journal:  J Chronic Dis       Date:  1985

9.  Diary keeping in asthma: comparison of written and electronic methods.

Authors:  M E Hyland; C A Kenyon; R Allen; P Howarth
Journal:  BMJ       Date:  1993-02-20

10.  Accuracy of perception of severity of asthma: patients treated in general practice.

Authors:  A H Kendrick; C M Higgs; M J Whitfield; G Laszlo
Journal:  BMJ       Date:  1993-08-14
View more
  11 in total

Review 1.  Quality-of-life measures as providers of information on value-for-money of health interventions. Comparison and recommendations for practice.

Authors:  M E Hyland
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

2.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Quality-of-life measures in asthma--do they matter to the GP?

Authors:  K Gruffydd-Jones
Journal:  Br J Gen Pract       Date:  1997-06       Impact factor: 5.386

4.  Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.

Authors:  N Kheir; L Emmerton; J Shaw
Journal:  J Sci Res Med Sci       Date:  2001-10

Review 5.  Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

Authors:  D H Peters; D Faulds
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 6.  Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

Authors:  Francine M Ducharme; Muireann Ni Chroinin; Ilana Greenstone; Toby J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

7.  Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.

Authors:  M P Rutten-van Mölken; E K van Doorslaer; M D Till
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 8.  Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

Authors:  Francine M Ducharme; Muireann Ni Chroinin; Ilana Greenstone; Toby J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

9.  Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial.

Authors:  G T Lewith; A D Watkins; M E Hyland; S Shaw; J A Broomfield; G Dolan; S T Holgate
Journal:  BMJ       Date:  2002-03-02

Review 10.  Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.

Authors:  Muireann Ni Chroinin; Ilana Greenstone; Toby J Lasserson; Francine M Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.